UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
UK & Europe · page 3
- CBD Market
Latest French CBD Crackdown To Be Challenged In Court
French trade groups are seeking to overturn the ban on the sale of CBD food supplements in an attempted re-run of the successful 2022 removal of the ban on the sale of flowers.
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Industry Trends
Jersey’s Cannabis Industry Posts First Profit as Exports Triple, But the Real Value Is Still Leaving the Island
Jersey’s medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in cumulative investment, and exports of nearly seven tonnes.
- Industry Trends
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Medical Cannabis
The Right Reforms, the Wrong Narrative: Why the Medical Cannabis Debate Is Missing Half the Picture
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
- Medical Cannabis
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure.
- UK & Europe
Züri Can Extended By Two Years As Results Point To Black Market Deterrence
Zurich’s municipal parliament has voted to extend its flagship adult-use cannabis pilot, Züri Can, by a further two years to October 2028, and to provide an additional CHF 800,000 in funding, in a 101-13 vote that laid bare the fault lines in Swiss cannabis politics.
- Medical Cannabis
Oliver’s Law: The Campaign That Could Reshape UK Cannabis Prescribing
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis contributed to a death in the country.
- CBD Market
Has UK’s ‘Brexit Reset’ Derailed 5-Year CBD Approval Battle?
The UK CBD industry’s long and hard-fought battle to become the first in the world to receive official regulatory approval looks likely to have been in vain, as the Food Standards Agency (FSA) raises serious questions over whether the process can deliver before it is overtaken by an EU alignment initiative.
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
- Hemp Industry
UK Hemp Industry Has Everything It Needs Except the Law
The UK’s industrial hemp sector, and its potential, have been raised in Parliament nearly as many times in the first three months of 2026 as the entirety of 2025.
